Feldman, H. H., & Lane, R. (2007). Rivastigmine: A placebo controlled trial of twice daily and three times daily regimens in patients with Alzheimer's disease. BMJ Group.
Chicago-stil citatFeldman, Howard H., och Roger Lane. Rivastigmine: A Placebo Controlled Trial of Twice Daily and Three Times Daily Regimens in Patients With Alzheimer's Disease. BMJ Group, 2007.
MLA-referensFeldman, Howard H., och Roger Lane. Rivastigmine: A Placebo Controlled Trial of Twice Daily and Three Times Daily Regimens in Patients With Alzheimer's Disease. BMJ Group, 2007.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.